Le Lézard
Classified in: Health
Subjects: PDT, SVY

Green Health Docs opens Medical Marijuana Certification Clinics in Hagerstown, Cumberland, Baltimore and Waldorf, Maryland


FREDERICK, Md., Dec. 14, 2017 /PRNewswire/ -- In 10 months, Green Health Docs has officially become Maryland's premier medical marijuana evaluation practice. With 6 locations statewide and rave reviews on Google and Yelp, Green Health Docs is changing the doctor-patient experience for the better and allowing patients to get access to medical marijuana. Frederick, Maryland, the practice's first location, opened on February 20, 2017.  Since then, owner, Dr. Shivani Amin, has expanded the practice to include locations in Cumberland, Hagerstown, Rockville, Baltimore and Waldorf.

To learn more about Green Health Docs, please visit: www.greenhealthdocs.com/about-us

Green Health Docs logo

HOW TO QUALIFY FOR MEDICAL MARIJUANA IN MARLYAND:
It actually is really simple to qualify for medical cannabis and Green Health Docs has made it very simple to understand (https://greenhealthdocs.com/get-certified/).  You need to live in Maryland, have at least one documented medical condition (like chronic pain, depression, or PTSD but ANY condition can qualify), and see a certifying provider licensed by the Maryland Medical Cannabis Commission. Because not all physicians will participate in the medical marijuana program, Green Health Docs has opened 6 clinics across the state to make it easy for patients to come see a registered provider. Mike Woolf, COO, says "Most doctors aren't comfortable giving patients access to medical cannabis. We think differently here from our physician owners to our entire staff.  We see this as the future of medical care in many ways and we are excited to be leading the way in Maryland!"

HISTORY OF GREEN HEALTH DOCS AND MARIJUANA RESEARCH GOALS:
Green Health Docs is physician owned and operated and was formed for a specific purpose: to combat the nation's opioid epidemic. So far 3500 patients have visited one of the six Green Health Docs locations (https://greenhealthdocs.com/locations/maryland/) to become a legal medical marijuana patient. Over the course of this year, patients will be monitored via Pain, Quality of Life, and Mood Scales to show the improvement cannabis has in their lives.  "By becoming a Green Health Docs patient, not only will you get your medical cannabis card, but you will also be helping to shape and improve the lives of countless others via medical research," says Dr. Amin.  This is what separates Green Health Docs from the rest of the providers offering this service.

To contact Green Health Docs: www.greenhealthdocs.com  - Call/text 240-356-1000 or Email [email protected]

Contact for Media:
Shivani Amin, MD
240-274-4093
[email protected]

 

SOURCE Green Health Docs


These press releases may also interest you

at 22:03
The report titled "Carbon Dioxide Incubator Market by Product (Air Jacketed CO2 Incubators, Direct Heat CO2 Incubators, Water Jacketed CO2 Incubators), Capacity (100-200 Litre, Above 200 Litre, Below 100 Litre), Application, End User - Global...

at 22:00
The "Global Clinical In Vitro Diagnostic Medical Laboratory Services Market: Strategy & Trends with Volume & Price Forecasts by Chemistry, Hematology, Microbiology, Pathology, Covid-19, and Molecular Dx by Country. Updated with Impact of COVID-19"...

at 21:45
The "Molecular Diagnostics at the Point of Care. By Application, Technology, Place, Product and by Country. With Executive Guides and Customization 2023 - 2027 " report has been added to  ResearchAndMarkets.com's offering. Infectious disease Dx is...

at 21:30
The "Whole Genome and Exome Sequencing Markets by Application, Organism and Product with Executive and Consultant Guides. Includes Direct to Consumer Analysis. 2023 to 2027" report has been added to  ResearchAndMarkets.com's offering. Will all...

at 20:50
Pharma (1167.HK), a clinical-stage oncology company drugging the undruggable targets, today announced its 2023 annual results. The revenue was RMB63.5 million, the R&D investment was RMB372 million, the cash and cash equivalent at the end of 2023 was...

at 20:35
InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company announced that the first patient in China has been dosed in the Phase 1b clinical study of the combination of InnoCare's novel SHP2 (Src Homology 2 domain containing...



News published on and distributed by: